Evidence map›Paper›PMID 31088560›Full record

Observational studyRespiratory research2019

Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.

Florin Mihaltan, Yochai Adir, Adam Antczak, Konstantinos Porpodis, Vesna Radulovic, Nuno Pires, Geeuwke Jan de Vries, Andreas Horner, Samuel De Bontridder, Yunqin Chen and 3 more

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03031769 (Symptoms and Physical Activity in COPD Patients in Europe), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03031769 completednot on this map

Symptoms and Physical Activity in COPD Patients in Europe

TypeobservationalSponsorAstraZenecaRan2016 to 2017Enrolled2,176ConditionsCOPD
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Physical Activity, Depression and Quality of Life in COPD - Results from the CLARA II Study.International journal of chronic obstructive pulmonary disease · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients.International journal of chronic obstructive pulmonary disease · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Florin MihaltanDepartment of Pulmonology, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania. mihaltan@starnets.ro.
Yochai AdirFaculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Adam AntczakClinical Department of Pulmonology and Allergology, University Hospital, Lodz, Poland.
Konstantinos PorpodisThessaloniki University Medical School, Thessaloniki, Greece.
Vesna RadulovicMunicipal Institute for Lung Diseases and Tuberculosis, Belgrade, Serbia.
Nuno PiresHospital Santa Maria Maior, Barcelos, Portugal.
Geeuwke Jan de VriesZuyderland Ziekenhuis Sittard, Geleen, Netherlands.
Andreas HornerKepler University Hospital, Krankenhausstrasse 9, A4021, Linz, Austria.
Samuel De BontridderUZ Brussel, Laarbeeklaan 101, 1090, Jette, Belgium.
Yunqin ChenAstraZeneca Global R&D Information, Shanghai, China.
Anat ShavitAstraZeneca Germany, Wedel, Germany.
Silviu AlecuAstraZeneca Romania, Bucharest, Romania.ORCID http://orcid.org/0000-0001-7781-6575
Lukasz AdamekAstraZeneca Europe, Luton, UK.

Funding

AstraZeneca Europe Not applicable
6 · The paper itself

Abstract

backgroundThe burden of symptoms and risk of exacerbations are the main drivers of the overall assessment of the Chronic Obstructive Pulmonary Disease (COPD) and the adequate treatment approaches per current Global Initiative for Chronic Obstructive Lung Disease (GOLD). Physical activity has emerged as both functional outcome and non-pharmacological intervention in COPD patients, despite the lack of standardized measures or guidelines in clinical practice. This study aimed to explore in more depth the 24-h respiratory symptoms, the physical activity level (PAL) and the relationship between these two determinants in stable COPD patients.

methodsThis was a multinational, multicenter, observational, cross-sectional study conducted in ten European countries and Israel. Dedicated questionnaires for each part of the day (morning, daytime, night) were used to assess respiratory symptoms. PAL was evaluated with self- and interview-reported tools [EVS (exercise as vital sign) and YPAS (Yale Physical Activity Survey)], and physician's judgement. Patients were stratified in ABCD groups by 2013 and 2017 GOLD editions using the questionnaires currently recommended: modified Medical Research Council dyspnea scale and COPD Assessment Test.

resultsThe study enrolled 2190 patients (mean age: 66.9 years; male: 70.0%; mean % predicted FEV1: 52.6; GOLD groups II-III: 84.5%; any COPD treatment: 98.9%). Most patients (> 90%) reported symptoms in any part of the 24-h day, irrespective of COPD severity. PAL evaluations showed discordant results between patients and physicians: 32.9% of patients considered themselves completely inactive, while physicians judged 11.9% patients as inactive. By YPAS, the overall study population spent an average of 21.0 h/week performing physical activity, and 68.4% of patients were identified as sedentary. In any GOLD ABCD group, the percentage of inactive patients was high. Our study found negative, weak correlations between respiratory symptoms and self-reported PAL (p < 0.001).

conclusionsDespite regular treatment, the majority of stable COPD patients with moderate to severe disease experienced daily variable symptoms. Physical activity level was low in this COPD cohort, and yet overestimated by physicians. With evidence indicating the negative consequences of inactivity, its adequate screening, a more active promotion and regular assessment of physical activity are urgently needed in COPD patients for better outcomes.

trial registrationNCT03031769 , retrospectively registered, 23 Jan 2017.

Indexed as

InternationalitySedentary BehaviorAdultAgedCross-Sectional StudiesEuropeExerciseFemaleHumansIsraelMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSelf ReportCOPDGOLDPhysical activitySedentarismSPACESymptoms

Identifiers

PMID31088560
PMCPMC6518503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.